Homocysteine's Second Exit: The CBS Gate Your MTHFR Protocol Forgot

Six months into coaching, Jake sent a Tuesday morning text. "HR was 57 when I woke up. I slept seven hours straight. I have not slept seven hours straight since my twenties."

Jake is 40, day-shift hospital security supervisor, MTHFR carrier. Nothing in his training had changed. What had changed, seven days earlier, was a single supplement swap. We pulled the pyridoxine HCl out of his B-complex and replaced it with 50 mg of P5P (pyridoxal-5-phosphate). Riboflavin went to 50 mg. Methylfolate held at 800 mcg. Methylcobalamin at 1000 mcg.

That week was the moment his transsulfuration pathway came online. Resting heart rate, which had run 72 to 78 for years, settled into the high 50s and stayed there. The 112 pounds he eventually lost (308 to 196 across 9.5 months starting mid-2025) are the headline of the bigger story. The CBS gate finally opening is the story underneath.

The map most MTHFR writeups stop too early

Almost every MTHFR explainer ends at methionine. Folate reduces to 5-MTHF, methionine synthase remethylates homocysteine, SAMe gets made, you methylate DNA and neurotransmitters, done.

That map is half the picture. Homocysteine is a branch point with two exits, not one.

Exit one is remethylation. Methionine synthase uses methylcobalamin and 5-MTHF to convert homocysteine back to methionine. This is the loop everyone draws, and the loop MTHFR bottlenecks by limiting 5-MTHF supply.

Exit two is transsulfuration. Cystathionine beta-synthase (CBS) condenses homocysteine with serine to form cystathionine. Cystathionine gamma-lyase (CBG, sometimes called CSE) then cleaves cystathionine into cysteine, alpha-ketobutyrate, and ammonia. Cysteine becomes the rate-limiting substrate for glutathione and the direct precursor to taurine through cysteine dioxygenase.

Both CBS and CBG are pyridoxal-5-phosphate dependent. Not "B6 dependent" in the generic sense. Specifically P5P dependent. That distinction is the difference between a protocol that works and one that does not.

Why pyridoxine HCl underperforms P5P

Pyridoxine HCl is the cheap form in roughly 90 percent of multivitamins. To become active, it has to be phosphorylated by pyridoxal kinase and then oxidized by pyridoxine-5-phosphate oxidase (PNPO). PNPO is itself FMN dependent, meaning riboflavin dependent, meaning the same MTHFR carriers running low FAD and FMN status convert pyridoxine to P5P slowly too.

Three problems stack for shift workers with MTHFR variants. First, pyridoxine HCl at sustained high doses can produce sensory neuropathy, likely by occupying P5P binding sites without completing enzyme activity. Second, PNPO polymorphisms and low riboflavin blunt conversion at the liver. Third, circadian disruption from shift rotation reduces hepatic phosphorylation capacity at the exact hours the body needs it most.

Skip the conversion problem entirely. Supplement P5P directly. Clinical doses in CBS-focused protocols run 25 to 50 mg daily.

What the data actually says

Kruman et al. (2002, Journal of Neuroscience) demonstrated something uncomfortable. Cultured rat hippocampal neurons exposed to pathophysiologic homocysteine showed PARP activation, uracil misincorporation into DNA, and apoptosis that antioxidants alone did not rescue. The mechanism was dual: direct DNA strand breaks plus impaired base-excision repair, worsened by folate deficiency. In their model, homocysteine was not a passive cardiovascular marker. It was a direct neuronal genotoxin.

Miller (2003, Nutrition Reviews) laid out the coupled system every practitioner should internalize. B6 status governs transsulfuration flux. Transsulfuration flux governs glutathione synthesis. When B6 is marginal, CBS activity drops, homocysteine accumulates, and glutathione synthesis falls because cysteine never gets generated downstream. You get the worst of both ledgers at once: oxidative damage rising while your primary endogenous antioxidant runs dry. Folate and B12 alone can lower homocysteine modestly while leaving glutathione synthesis empty.

Clarke et al. (2010, American Journal of Clinical Nutrition) ran the VITACOG trial out of Oxford. 271 adults over 70 with mild cognitive impairment, randomized to 0.8 mg folic acid, 0.5 mg B12, and 20 mg B6 daily versus placebo, two years, primary outcome measured by serial MRI. The treatment arm lost whole-brain volume 30 percent more slowly than placebo. In the subgroup with baseline homocysteine above 13 umol/L, the atrophy reduction reached 53 percent.

Thirty percent slower atrophy. Two years. Per vitamins that cost less than coffee. A modern MTHFR protocol would swap the folic acid for methylfolate, but the rest of the logic holds, and the B6 dose was the one that saturated CBS cofactor demand.

Where cleared homocysteine actually goes

When CBS lights up, the carbon and sulfur skeleton of homocysteine ends up in cysteine, and cysteine has three fates.

Glutathione is the largest sink. Glutamate-cysteine ligase is rate-limited by cysteine availability, which is why NAC works as a precursor and why functioning CBS works better still: it is endogenous and regulated.

Taurine is the second sink. Cysteine dioxygenase oxidizes cysteine to cysteine sulfinate, which decarboxylates to hypotaurine and then taurine. Taurine modulates GABA-A receptors (sleep), conjugates bile acids (fat digestion), and contributes to cardiac electrical stability. A shift worker who cannot sleep on days off is sometimes a shift worker whose CBS is not producing taurine.

Hydrogen sulfide signaling is the third fate, produced in small quantities by both CBS and CBG, acting as a vasodilator and mitochondrial modulator.

All three outputs depend on getting homocysteine through the CBS gate. All three depend on P5P.

The shift worker stack

If you are 30 to 50, rotating shifts, and carrying MTHFR variants, you are running three simultaneous headwinds. Circadian disruption downregulates hepatic methylation throughput. MTHFR limits how much 5-MTHF you can produce, so more homocysteine has to leave through transsulfuration, raising P5P demand. Shift eating patterns skew refined and under-deliver on B6-dense foods like salmon, pistachios, poultry, chickpeas, and potatoes with skin, exactly when biological demand is highest.

Test before stacking. Fasting homocysteine, serum B12, RBC folate, and if budget allows plasma P5P and urinary methylmalonic acid. A homocysteine over 9 umol/L in a carrier under 50 is worth acting on. Target under 7 umol/L for cognitive protection, not the lab's nominal 15.

A transsulfuration-competent baseline:

• **Methylfolate (5-MTHF)** 400 to 800 mcg daily. Skip folic acid.
• **Methylcobalamin or hydroxocobalamin** 1000 mcg sublingual. Skip cyanocobalamin.
• **P5P (pyridoxal-5-phosphate)** 25 to 50 mg with breakfast. The CBS and CBG cofactor.
• **Riboflavin-5-phosphate** 25 to 50 mg daily. FAD governs MTHFR stability and PNPO conversion.
• **Trimethylglycine (betaine)** 1 to 3 g if homocysteine stays elevated. BHMT is an alternate remethylation route.
• **Magnesium glycinate** 300 to 400 mg in the evening. Glycine also feeds GSH synthesis through the serine-glycine cycle.
• **NAC or whey protein** for downstream cysteine support once CBS is flowing. Start low; if sulfur intolerance appears, back off and address ammonia clearance and B12 first.

Food for the sulfur side: pastured eggs daily (cysteine, choline, B12), crucifers four times per week (sulforaphane upregulates NRF2 and glutathione synthesis), grass-fed beef twice per week (glycine plus cysteine plus B12), and bone broth or collagen three times per week (glycine is the second GSH substrate and the rate limiter most people miss).

Training: compound lifts three days per week, zone 2 cardio twice per week at 60 to 70 percent max HR, and protected sleep windows around any overnight rotations. Homocysteine rises with psychological stress and falls with consistent aerobic output. Both are training variables.

Retest at 8 to 12 weeks.

The point

Overmethylation symptoms in MTHFR carriers are often misread CBS strain. You push more methylfolate, homocysteine bottlenecks at CBS, sulfur chemistry stalls, and the person feels worse. The fix is not less methylfolate. The fix is opening the downstream gate.

Homocysteine has two exits. If MTHFR is narrowing the first one, the second one had better be open. P5P is the key to the lock. Riboflavin keeps the key from rusting. Glycine and cysteine are what flows through the open door.

Brains losing volume 30 percent slower over two years is what happens when the gate works.